Luis Manuel Sanchez Navarro
Overview
Explore the profile of Luis Manuel Sanchez Navarro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Velazquez-Enriquez J, Ramirez-Hernandez A, Navarro L, Reyes-Avendano I, Gonzalez-Garcia K, Jimenez-Martinez C, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563422
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, irreversible lung disorder of unknown cause. This disease is characterized by profibrotic activation of resident pulmonary fibroblasts resulting in aberrant deposition of...
2.
Hernandez-Huerta M, Perez-Santiago A, Perez-Campos Mayoral L, Navarro L, Rodal Canales F, Majluf-Cruz A, et al.
Biomolecules
. 2021 Nov;
11(11).
PMID: 34827548
SARS-CoV-2 contains certain molecules that are related to the presence of immunothrombosis. Here, we review the pathogen and damage-associated molecular patterns. We also study the imbalance of different molecules participating...
3.
Rodal Canales F, Perez-Campos Mayoral L, Hernandez-Huerta M, Navarro L, Matias-Cervantes C, Martinez Cruz M, et al.
Sci Rep
. 2021 Nov;
11(1):22288.
PMID: 34782703
Numerous repositioned drugs have been sought to decrease the severity of SARS-CoV-2 infection. It is known that among its physicochemical properties, Ursodeoxycholic Acid (UDCA) has a reduction in surface tension...
4.
Perez-Campos Mayoral L, Hernandez-Huerta M, Papy-Garcia D, Barritault D, Zenteno E, Navarro L, et al.
Mol Cell Biochem
. 2021 Jun;
476(10):3815-3825.
PMID: 34110554
Chagas and COVID-19 are diseases caused by Trypanosoma cruzi and SARS-CoV-2, respectively. These diseases present very different etiological agents despite showing similarities such as susceptibility/risk factors, pathogen-associated molecular patterns (PAMPs),...
5.
Castillejos F, Perez-Campos Mayoral L, Andrade G, Hernandez-Huerta M, Pina-Canseco S, Martinez Cruz R, et al.
Trop Biomed
. 2021 Feb;
35(3):678-683.
PMID: 33601755
The chronic indeterminate phase of Chagas' disease is asymptomatic despite positive test results for antibodies specific to Trypanosoma cruzi. CD62P-APC (P-selectin) and PAC-1 FITC (GpIIb/IIIa) may improve diagnosis as biomarkers...
6.
Hernandez-Huerta M, Perez-Campos Mayoral L, Diaz C, Martinez Cruz M, Mayoral-Andrade G, Navarro L, et al.
J Med Virol
. 2020 Oct;
93(4):2099-2114.
PMID: 33049069
The genomic sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide are publicly available and are derived from studies due to the increase in the number of cases. The...
7.
Hernandez-Huerta Ph D M, Perez-Campos Mayoral Ph D L, Navarro L, Mayoral-Andrade Ph D G, Perez-Campos Mayoral Ph D E, Zenteno Ph D E, et al.
J Med Virol
. 2020 Jun;
93(1):137-138.
PMID: 32592498
No abstract available.